Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 35.80M | 26.34M | 20.15M | 9.50M | 7.91M |
Gross Profit | -1.68M | 12.43M | 3.91M | 1.90M | 6.15M |
EBITDA | -19.45M | 4.84M | -1.89M | -9.65M | -5.07M |
Net Income | -22.55M | -5.07M | -7.54M | -11.23M | -10.17M |
Balance Sheet | |||||
Total Assets | 59.47M | 82.55M | 67.03M | 50.57M | 40.80M |
Cash, Cash Equivalents and Short-Term Investments | 1.74M | 794.00K | 6.78M | 14.49M | 625.00K |
Total Debt | 17.01M | 18.70M | 3.01M | 623.00K | 7.50M |
Total Liabilities | 26.62M | 33.22M | 18.79M | 2.70M | 12.38M |
Stockholders Equity | 32.85M | 49.33M | 43.92M | 47.87M | 28.42M |
Cash Flow | |||||
Free Cash Flow | 401.00K | 1.85M | -4.90M | -6.22M | -1.12M |
Operating Cash Flow | 507.00K | 5.41M | -3.46M | -5.62M | -357.00K |
Investing Cash Flow | -78.00K | -7.03M | -3.10M | -1.65M | -1.38M |
Financing Cash Flow | 539.00K | -4.38M | -993.00K | 20.96M | 393.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
57 Neutral | $8.64M | ― | -63.75% | ― | 9.34% | 69.69% | |
56 Neutral | C$6.88M | 181.82 | -3.45% | ― | 4.04% | 80.24% | |
50 Neutral | C$7.49M | ― | -55.81% | ― | 31.94% | -45.55% | |
50 Neutral | $9.92M | 6.82 | -22.29% | ― | 28.30% | 86.67% | |
46 Neutral | C$205.70M | -3.34 | -23.14% | 2.45% | 20.79% | -0.36% |
Avant Brands Inc. reported its financial results for Q2 2025, highlighting a 3% increase in both gross and net revenue compared to Q2 2024. The company achieved its sixth consecutive quarter of positive Adjusted EBITDA, driven by a significant 11% rise in export wholesale revenue and a 31% increase in domestic wholesale revenue. Avant’s strategic focus on high-margin products has led to a decline in recreational revenue, but this realignment is expected to enhance long-term profitability. The company’s strong international presence and operational discipline continue to solidify its position as a leading Canadian cannabis exporter.
Avant Brands Inc. has announced strategic international supply agreements to export up to 2,000 kilograms per year of GACP-certified, non-irradiated dried flower to the European medical cannabis market, enhancing its global market presence. Additionally, Avant is expanding its product offerings in Canada with over 30 new SKU listings in Ontario and B.C., introducing innovative packaging and products, and relaunching its medical division to better serve Canadian patients and veterans, marking a pivotal moment in its growth trajectory.
Avant Brands Inc. held its 2025 Annual General Meeting, where 16.19% of its common shares were represented. Key outcomes included the election of six directors, re-appointment of Ernst & Young LLP as auditors, and approval of amendments to the company’s deferred share unit and long-term incentive plans. Additionally, the repricing of certain warrants and convertible debentures was approved, reflecting strategic adjustments to enhance shareholder value and operational flexibility.